The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients-Reference-Cited by-同舟云学术

The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients

Published:2014-05-23 Issue:8 Volume:35 Page:8259-8265
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Li Xiang-Ping,Yin Ji-Ye,Wang Ying,He Hui,Li Xi,Gong Wei-Jing,Chen Juan,Qian Chen-Yue,Zheng Yi,Li Fang,Yin Tao,Gong Zhi-Cheng,Zhou Bo-Ting,Zhang Yu,Xiao Ling,Zhou Hong-Hao,Liu Zhao-Qian

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-014-2072-0.pdf

Reference39 articles.

1. Wheate NJ, Walker S, Craig GE, Oun R. The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton Trans. 2010;39:8113–27.

2. Stordal B, Davey M. Understanding cisplatin resistance using cellular models. IUBMB life. 2007;59:696–9.

3. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7:573–84.

4. Shahzad MM, Lopez-Berestein G, Sood AK. Novel strategies for reversing platinum resistance. Drug Resist Updat: Rev Commentaries Antimicrob Anticancer Chemother. 2009;12:148–52.

5. La Fontaine S, Mercer JF. Trafficking of the copper-atpases, atp7a and atp7b: Role in copper homeostasis. Arch Biochem Biophys. 2007;463:149–67.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An original cuproptosis-related genes signature effectively influences the prognosis and immune status of head and neck squamous cell carcinoma;Frontiers in Genetics;2023-01-04

2. Development and validation of a polygenic hazard score to predict prognosis and adjuvant chemotherapy benefit in early-stage non-small cell lung cancer;Translational Lung Cancer Research;2022-09

3. Cuproptosis-Related Gene – SLC31A1, FDX1 and ATP7B – Polymorphisms are Associated with Risk of Lung Cancer;Pharmacogenomics and Personalized Medicine;2022-07

4. Association between ABCC2 polymorphism and hematological toxicity in patients with esophageal cancer receiving platinum plus 5-fluorouracil therapy;Esophagus;2021-08-04

5. Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy;Cancer Chemotherapy and Pharmacology;2021-07-26